Want to join the conversation?
$BAX's research and development, or R&D, expenditures for 2015 slid to $603MM from $610MM last year. These expenditures include costs associated with R&D actvities performed at R&D centers located around the world, as well as in-licensing, milestone and reimbursement payments made to partners for R&D work performed at non-$BAX locations.
Keep your eyes on $FLXN. This one could ascend rapidly. Great time to buy your favourite bio stocks. Make more $$$
$CRM on the pop today.. big bubble.
Slumping and down the drain... $HDSN. Flush out your holdings !
$KITE I am loving this one... really flying like a kite today :-)